OCT4‑positive circulating tumor cells may predict a poor prognosis in patients with metastatic castration‑resistant prostate cancer treated with abiraterone plus prednisone therapy.

Authors:
Ma Y.

Journal:
Oncol Lett

Publication Year: 2023

DOI:
10.3892/ol.2023.14039

PMCID:
PMC10502952

PMID:
37720669

Journal Information

Full Title: Oncol Lett

Abbreviation: Oncol Lett

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The author declares that they have no competing interests."

Evidence found in paper:

"Funding: No funding was received."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025